This platform is currently totally free and created by doctors. 🩺
Menu
HomeClinical ProtocolsProtocol Details

POSTPARTUM HAEMORRHAGE (PPH)

Verified clinical guidelines and emergency management protocols.

Protocol Content

Navigation

🔴 POSTPARTUM HAEMORRHAGE (PPH)

COMPREHENSIVE CLINICAL PROTOCOL FOR INDIAN HEALTHCARE SETTINGS


For Healthcare Professionals Only | Aligned with WHO 2023, FIGO 2022, FOGSI, LaQshya Guidelines

SECTION 1: FUNDAMENTALS


1.1 DEFINITIONS

Term Definition Clinical Significance
PPH (Traditional - Vaginal)
Blood loss ≥500 mL after vaginal delivery Threshold for documentation; often underestimates true loss
PPH (Traditional - CS)
Blood loss ≥1000 mL after caesarean section Higher baseline expected loss in CS
Severe PPH
Blood loss ≥1000 mL regardless of mode Requires aggressive intervention
Clinical PPH (Preferred)
Blood loss causing haemodynamic instability OR requiring intervention Most practical definition; treat the patient, not the number
Primary PPH
Within 24 hours of delivery Most common, most dangerous
Secondary PPH
24 hours to 12 weeks postpartum Usually infection or retained products
🚨 Clinical Pearl: Visual estimation underestimates blood loss by 30-50%. A soaked maternity pad holds ~100 mL; a soaked under-buttock drape holds ~500-1000 mL. When in doubt, treat as PPH.

1.2 EPIDEMIOLOGY (INDIA-SPECIFIC)

Parameter Data
Incidence 2-4% of all deliveries; up to 6% in some settings
Maternal mortality contribution 38% of direct maternal deaths (leading cause)
Case fatality rate 1% (higher in rural/resource-limited settings)
Time to death Can occur within 2 hours if untreated
Why Indian Women Are More Vulnerable:
  • High prevalence of anaemia (Hb <11 g/dL in >50% of pregnant women)
  • Malnutrition
  • High fertility rates
  • Home deliveries without skilled attendants
  • Delayed recognition and referral
  • Limited blood bank access

1.3 AETIOLOGY: THE 4 Ts (In Order of Frequency)

TONE (70-80%) – Uterine Atony
Risk Factors Mechanism
Overdistended uterus
Multiple pregnancy, polyhydramnios, macrosomia (>4 kg)
Uterine muscle fatigue
Prolonged labour, rapid labour (precipitate), prolonged oxytocin use
Uterine muscle impairment
Grand multiparity (≥5), previous PPH, fibroids, chorioamnionitis
Drug-induced relaxation
MgSO₄, tocolytics (terbutaline, nifedipine), halogenated anaesthetics
Other
Full bladder (prevents contraction), uterine inversion
TRAUMA (10-20%) – Genital Tract Injury
Type Causes Clinical Features
Perineal tears
Precipitate delivery, large baby, instrumental delivery Visible bleeding from perineum
Vaginal tears
Instrumental delivery, malpresentation Bleeding with contracted uterus
Cervical tears
Rapid dilatation, pushing before full dilatation Bleeding despite contracted uterus; need speculum exam
Uterine rupture
Previous CS, obstructed labour, oxytocin excess Sudden pain, shock, loss of contractions
Uterine inversion
Cord traction before separation, fundal pressure Mass at/outside introitus, shock out of proportion
Broad ligament haematoma
Extension of uterine incision (CS), instrumental Expanding pelvic mass, shock
TISSUE (5-10%) – Retained Products
Type Causes Clinical Features
Retained placenta
Placenta accreta spectrum, manual removal failure Placenta not delivered within 30 min
Retained cotyledon/membrane
Incomplete placental examination Uterus doesn’t contract fully; check placenta
Retained blood clots
Atony, coagulopathy Soft uterus despite uterotonics; clots on massage
Succenturiate lobe
Abnormal placentation Vessels running to edge of membranes
THROMBIN (1-2%) – Coagulopathy
Type Causes Clinical Features
Pre-existing
Von Willebrand disease, haemophilia carriers, ITP, anticoagulant use Known history; bleeding from multiple sites
Acquired - Pregnancy
Severe preeclampsia/HELLP, placental abruption, amniotic fluid embolism, IUFD (especially >4 weeks) Oozing from IV sites, wound, no clot formation
Acquired - Dilutional
Massive crystalloid resuscitation, massive transfusion without FFP After large volume replacement
DIC
Abruption, sepsis, AFE, IUFD Consumptive; low fibrinogen, prolonged PT/aPTT

1.4 RISK STRATIFICATION

Antenatal Risk Assessment
Risk Level Factors Action
HIGH RISK
Previous PPH, placenta praevia, suspected accreta, multiple pregnancy, polyhydramnios, large fibroids, bleeding disorder, severe anaemia (Hb <7), anticoagulant use Deliver at CEmONC facility with blood bank; Group & Save/Crossmatch; senior obstetrician; anaesthesia standby
MODERATE RISK
Grand multiparity (≥5), previous CS, overdistended uterus, Hb 7-9, obesity Deliver at facility with blood transfusion capability; Group & Save; IV access before delivery
LOW RISK
No risk factors identified Routine AMTSL; be prepared (PPH can occur without risk factors)
⚠️ 40% of PPH occurs in women with NO identifiable risk factors. Always be prepared.
Intrapartum Risk Assessment (Reassess Continuously)
New Risk Factor Action
Prolonged first stage (>12h nullipara, >10h multipara) Prepare blood, senior involvement
Prolonged second stage Consider instrumental vs CS; have uterotonics ready
Chorioamnionitis IV antibiotics; anticipate atony
Instrumental delivery Check for trauma; have sutures ready
Emergency CS Anticipate higher blood loss
MgSO₄ use Atony risk increased

SECTION 2: PREVENTION


2.1 ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR (AMTSL)

Reduces PPH by 60-70% – Should be offered to ALL women
Components
Component Technique Timing
1. Prophylactic Uterotonic
Oxytocin 10 IU IM (preferred) OR IV over 1-2 min Within 1 minute of delivery of baby
2. Controlled Cord Traction (CCT)
Apply steady traction on cord while providing counter-traction above pubic symphysis Only when uterus contracted and cord lengthening
3. Uterine Massage
Gentle fundal massage after placental delivery Until uterus well-contracted
Preferred Uterotonic for Prophylaxis
Drug Dose Route Notes
Oxytocin
10 IU IM (preferred) or slow IV First choice; safest profile
Carbetocin
100 mcg Single IM/IV dose Longer acting; useful where cold chain limited
Oxytocin + Ergometrine (Syntometrine)
5 IU + 0.5 mg IM More effective but more side effects; avoid in HTN
Misoprostol
600 mcg Oral Where oxytocin unavailable; more side effects
Controlled Cord Traction Technique
TECHNIQUE:
1. Wait for signs of placental separation:
- Uterus becomes globular and firm
- Gush of blood
- Cord lengthens
- Uterus rises in abdomen
2. Clamp cord close to perineum; hold with one hand
3. Place other hand suprapubically, palm facing toward
umbilicus (counter-traction hand)
4. Apply steady, gentle downward traction on cord while
pushing uterus upward/backward with counter-traction hand
5. If placenta doesn't descend with 30-40 sec of traction:
- Stop pulling
- Wait for next contraction
- Try again
6. Once placenta visible at introitus, use both hands to
gently rotate and ease out membranes
7. NEVER use excessive force – risk of uterine inversion
Examination of Placenta
CHECKLIST:
□ Maternal surface: All cotyledons present? Missing piece?
□ Fetal surface: Vessels run to edge? (succenturiate lobe if yes)
□ Membranes: Complete? Hole suggesting missing lobe?
□ Cord: Length, insertion, number of vessels (2 arteries, 1 vein)
□ Abnormalities: Infarcts, calcifications, tumours
DOCUMENT: Placenta complete/incomplete, weight if abnormal,
sent for histopathology if indicated

2.2 DELAYED CORD CLAMPING

Recommendation Details
Timing Clamp cord 1-3 minutes after delivery (if baby vigorous)
Benefit Increased neonatal haemoglobin, iron stores
Exception If mother bleeding heavily OR baby needs resuscitation → clamp immediately

2.3 PREPARING FOR PPH (HIGH-RISK CASES)

Pre-Delivery Checklist (High-Risk Woman)
□ IV access established (16-18G, preferably 2 lines)
□ Blood group and crossmatch sent (2-4 units PRBC)
□ Hb, platelets, coagulation if indicated
□ Uterotonics at bedside:
- Oxytocin 10 IU ampules × 5
- Misoprostol 200 mcg tablets × 5
- Methylergometrine 0.2 mg × 2 (if no contraindication)
- Carboprost 250 mcg × 2 (if available, no contraindication)
□ Tranexamic acid 1 g × 2 at bedside
□ IV fluid (NS/RL) running or ready
□ Blood warmer and pressure bag available
□ UBT (Uterine Balloon Tamponade) kit available
□ Senior obstetrician informed
□ Anaesthesia informed
□ Blood bank informed of high-risk case
□ Neonatal team standby
□ Emergency OT on standby (for highest risk: accreta)

SECTION 3: RECOGNITION AND INITIAL RESPONSE


3.1 RECOGNITION

Clinical Signs of PPH
Sign What to Look For
Visible bleeding
Continuous trickle, gush, soaking drapes, pooling
Uterine fundus
Soft, boggy, above umbilicus (atony) vs firm (trauma/tissue)
Vital signs
Tachycardia, hypotension, tachypnoea
Patient symptoms
Weakness, dizziness, thirst, confusion, restlessness
Appearance
Pallor, cold/clammy, air hunger
Obstetric Shock Index (OSI)
Shock Index = Heart Rate ÷ Systolic Blood Pressure
SI Value Interpretation Estimated Blood Loss Required Action
0.7-0.9 Normal <500 mL Monitor, continue routine care
0.9-1.1 Mild shock 500-1000 mL Alert team, prepare interventions
1.1-1.5 Moderate shock 1000-1500 mL
Aggressive intervention
>1.5 Severe shock >1500 mL
Massive transfusion protocol
🚨 Why Shock Index Matters: Pregnant women maintain BP until 30-40% blood volume lost due to physiological hypervolaemia. By the time BP drops, patient is in severe shock. Tachycardia and rising SI are earlier warning signs.
Quantitative Blood Loss Measurement
Method Technique
Weighing
Weigh blood-soaked items; 1 g = 1 mL blood (subtract dry weight)
Graduated drapes
Calibrated under-buttock drapes
Estimation aids
Visual guides showing soaked swabs, drapes, etc.
Visual Estimation Guide:
Item Approximate Blood Volume
Fully soaked maternity pad 100 mL
Fully soaked incontinence pad (large) 250 mL
Blood clot (fist-sized) 500 mL
Fully soaked under-buttock drape 500-1000 mL
Kidney dish (full) 500 mL

3.2 CALL FOR HELP – FIRST ACTION

🚨 PPH DECLARED – IMMEDIATELY:
□ Call: "I need help – PPH in [location]"
□ Designate:
- Team leader (usually senior obstetrician)
- Person for drugs/fluids
- Person for documentation/time-keeping
- Person for communication (blood bank, OT, ICU)
□ Start timer (or note time)
□ Inform:
- Senior obstetrician (if not present)
- Anaesthetist
- Blood bank
- Nursing supervisor (for additional staff)
□ Move PPH trolley/kit to bedside
PPH Trolley Contents:
Category Items
Uterotonics
Oxytocin 10 IU × 10, Misoprostol 200 mcg × 10, Methylergometrine 0.2 mg × 5, Carboprost 250 mcg × 4 (refrigerated)
Tranexamic acid
1 g ampules × 4
IV supplies
16G & 18G cannulas × 4 each, IV sets × 4, 3-way stopcock × 2
Fluids
NS 1L × 4, RL 1L × 4
Blood administration
Blood giving sets × 4, blood warmer if available
UBT
Bakri balloon OR Condom catheter kit (Foley 22-24F, condom, silk tie)
Instruments
Sponge holding forceps × 2, ovum forceps, Sims speculum, suture material
Drugs
Calcium gluconate 10% × 2, Adrenaline 1:1000 × 2, Atropine × 2
Monitoring
BP cuff, pulse oximeter, thermometer
Documentation
PPH checklist, observation chart, timer

3.3 INITIAL RESUSCITATION (FIRST 5 MINUTES)

A – Airway and Breathing
Action Details
Position Flat with legs elevated OR left lateral if still in labour
Airway Ensure patent; suction if vomiting
Oxygen 8-10 L/min via face mask with reservoir (target SpO₂ ≥95%)
C – Circulation
Action Details
IV Access
2 large-bore cannulas (16G or 18G) – antecubital fossa preferred
If difficult: external jugular, femoral, or intraosseous (EZ-IO)
Bloods
CBC, Group & crossmatch, PT/aPTT/fibrinogen, RFT, LFT
ABG with lactate if available
Crystalloid
1-2 L NS or RL rapid bolus (use pressure bag/hand squeeze)
Warming
Warm fluids if possible; warm blankets
Catheterize
Insert Foley; empty bladder (helps uterine contraction); monitor output
Fluid Resuscitation Strategy
Phase Volume Endpoint
Initial bolus
1-2 L crystalloid over 10-15 min Assess response
Ongoing
Titrate to response SBP >90, MAP ≥65, UO ≥0.5 mL/kg/hr
Caution
Avoid >2L crystalloid without blood Dilutional coagulopathy, pulmonary oedema
⚠️ Crystalloid replaces volume, not oxygen-carrying capacity. In ongoing haemorrhage, early blood is critical.

SECTION 4: CAUSE IDENTIFICATION AND TARGETED TREATMENT


4.1 SIMULTANEOUS ASSESSMENT (While Resuscitating)

RAPID ASSESSMENT CHECKLIST:
□ UTERUS: Palpate fundus
- Soft/boggy → ATONY (most likely)
- Firm/contracted → Look for TRAUMA or TISSUE
□ VAGINA/PERINEUM: Inspect
- Active bleeding from tear → TRAUMA
- Clots in vagina → Empty and reassess
□ PLACENTA: Check
- Not delivered → Retained placenta
- Incomplete → Retained tissue
- Complete → Reassess cause
□ CERVIX: Speculum exam (if uterus contracted)
- Cervical tear → TRAUMA
□ BLEEDING CHARACTER:
- Clotting normally → Unlikely THROMBIN defect
- Not clotting, oozing from IV sites → THROMBIN issue

4.2 TREATMENT BY CAUSE

TONE – Uterine Atony Management
Step 1: Uterine Massage (Immediate)
TECHNIQUE – BIMANUAL UTERINE MASSAGE:
External only (initial):
- Cup hand over fundus through abdomen
- Firm, circular, rubbing motion
- "Rub up a contraction"
Bimanual (if no response):
- One hand: Fist in anterior vaginal fornix,
pushing up against lower segment
- Other hand: On abdomen, pressing down on fundus
- Compress uterus between both hands
- Maintain for several minutes until firm
- Can be tiring – may need to rotate personnel
Step 2: Empty Bladder
  • Insert Foley catheter if not already done
  • Full bladder prevents uterine contraction
  • Also allows urine output monitoring
Step 3: Uterotonics (Start All Indicated Simultaneously)
Drug Dose & Route Onset Notes
Oxytocin (First line)
10 IU IM OR slow IV (over 1-2 min) 2-3 min (IM), immediate (IV) Maximum bolus 10 IU
Oxytocin infusion
20-40 IU in 500 mL NS at 125-250 mL/hr Continuous Titrate to uterine tone; max ~60 IU total
Misoprostol
800 mcg sublingual (fastest) OR 1000 mcg rectal 10-15 min Use if oxytocin unavailable or as add-on; SE: fever, shivering
Methylergometrine
0.2 mg IM (preferred) or slow IV 2-5 min ❌ Contraindicated: HTN, preeclampsia, cardiac disease
Carboprost (PGF2α)
250 mcg deep IM q15-20 min (max 8 doses = 2 mg) 5-15 min ❌ Contraindicated: asthma, pulmonary/cardiac/renal disease; store refrigerated
Carbetocin
100 mcg single IV/IM dose Similar to oxytocin Longer acting; may use instead of oxytocin infusion
Uterotonic Escalation Protocol:
TIME 0: PPH recognized
├── Oxytocin 10 IU IM/IV + Start oxytocin infusion
├── Continue uterine massage
+5 min: Assess – if still bleeding/atonic
├── Add Misoprostol 800 mcg SL
├── Consider Methylergometrine 0.2 mg IM (if no contraindication)
+10-15 min: Assess – if still bleeding/atonic
├── Add Carboprost 250 mcg IM (if no contraindication)
├── Prepare for mechanical/surgical interventions
+15-20 min: Assess – if still bleeding
├── Proceed to UBT or surgical options
🚨 Do NOT delay escalation. Time is critical. All uterotonics can be given together if needed.
Step 4: Tranexamic Acid (Give Early)
Parameter Details
Dose
1 g (10 mL of 100 mg/mL solution) IV over 10 minutes
Timing
As soon as PPH diagnosed – within 3 hours of birth
Repeat
Second 1 g IV if bleeding continues after 30 minutes OR if bleeding restarts within 24 hours
Evidence
WOMAN Trial: 20-30% reduction in death from bleeding if given within 3 hours
Mechanism
Inhibits plasmin → reduces fibrin breakdown → stabilizes clot
🚨 TXA efficacy decreases 10% for every 15 minutes of delay. NO BENEFIT after 3 hours. Give EARLY.
Contraindications to TXA (rare in acute PPH):
  • Active thromboembolic disease
  • Clear contraindication to antifibrinolytics
  • In practice, these rarely apply in acute PPH – save life first

TRAUMA – Genital Tract Injury Management
Systematic Examination
EXAMINATION SEQUENCE:
1. GOOD LIGHTING – essential
2. ADEQUATE EXPOSURE – legs in lithotomy
3. ADEQUATE ANALGESIA – local, regional, or GA as needed
4. ASSISTANT – to hold retractors
Start from outside, work in:
□ PERINEUM:
- First/second degree tears → Repair
- Third/fourth degree → Senior surgeon, OT, proper repair
□ VAGINA:
- Use Sims speculum or retractors
- Inspect all walls systematically
- Pack and clamp bleeding areas
□ CERVIX:
- Use sponge-holding forceps to grasp lips
- Inspect entire circumference
- Common at 3 o'clock and 9 o'clock positions
□ UTERUS:
- If rupture suspected → laparotomy
- If inversion → manual replacement
Repair Principles
Injury Management
Perineal tear (1st-2nd degree)
Suture in layers; vaginal mucosa → perineal muscle → skin
Perineal tear (3rd-4th degree)
OT, experienced surgeon, proper identification of anal sphincter, layered repair, antibiotics, laxatives postop
Vaginal tear
Suture from apex to avoid retraction and haematoma; continuous or interrupted
Cervical tear
Start suture above apex of tear; continuous locking or interrupted; may need traction with sponge forceps
Broad ligament haematoma
Laparotomy if expanding; evacuate, identify bleeding vessel, ligate; may need internal iliac ligation
Uterine rupture
See Section 7 of main document
Uterine inversion
See Section 8 of main document
⚠️ Always inspect placenta and genital tract even if uterus well-contracted – trauma can coexist with atony

TISSUE – Retained Products Management
Retained Placenta (Not Delivered by 30 min)
Situation Management
Placenta not delivered, no haemorrhage Ensure bladder empty; controlled cord traction; wait up to 30-60 min
Placenta not delivered, haemorrhage present
Manual removal under anaesthesia
Trapped placenta (cervix closing) May need uterine relaxation (terbutaline, nitroglycerin, GA)
Morbidly adherent (accreta spectrum) Senior surgeon, interventional radiology if available, prepare for hysterectomy
Manual Removal of Placenta – Technique:
PREREQUISITES:
- Anaesthesia (regional or GA)
- Aseptic technique
- IV access and resuscitation ongoing
- Empty bladder
TECHNIQUE:
1. One hand on abdomen, steadying fundus (counter-traction)
2. Other hand (surgeon's dominant): Cone shape, follow cord
through cervix into uterine cavity
3. Find placental edge – use side of hand to develop plane
between placenta and uterine wall
4. Work around circumference with gentle side-to-side motion
5. Once fully separated, grasp placenta and withdraw
6. Immediately explore cavity for remaining fragments
7. Administer uterotonic and massage uterus
8. Confirm complete removal (examine placenta)
9. Single dose antibiotics (Ceftriaxone 1g IV or Ampicillin 2g IV)
⚠️ If plane cannot be developed (rock-hard adherence) →
STOP – suspect placenta accreta → prepare for laparotomy/hysterectomy
Retained Tissue/Clots (Placenta Delivered but Incomplete/Uterus Full of Clots)
Situation Management
Retained cotyledon/membranes Explore uterine cavity under anaesthesia; gentle curettage with large blunt curette (avoid perforation)
Retained blood clots preventing contraction Bimanual compression to express clots; may need manual exploration
Secondary PPH (>24h) with retained products Ultrasound guidance; surgical evacuation; antibiotics

THROMBIN – Coagulopathy Management
Recognition
Sign What It Means
Blood not clotting in wound/drapes Clotting factor deficiency
Oozing from IV sites, gums, old punctures Systemic coagulopathy
Ecchymoses appearing Platelet/factor deficiency
Bedside clotting test abnormal DIC or factor deficiency
Bedside Clotting Test (Modified Lee-White):
1. Take 5 mL blood in plain glass tube (red-top)
2. Hold at body temperature (in your armpit or hands)
3. Tilt gently every minute
4. Normal: Firm clot in <8-10 minutes
5. Abnormal: No clot or soft/friable clot by 10 minutes →
Suspect coagulopathy; treat empirically while awaiting labs
Treatment
Component Product Dose Target
Red cells
PRBC Transfuse for Hb <7-8 g/dL or ongoing bleeding Hb >7-8 g/dL
Clotting factors
FFP 15-20 mL/kg (typically 4-6 units) PT/aPTT <1.5× control
Fibrinogen
Cryoprecipitate 10 units (or 1 pool) Fibrinogen >2 g/L
Fibrinogen concentrate 2-4 g (if available) Fibrinogen >2 g/L
Platelets
Platelet concentrate 1 adult dose (4-6 units or 1 SDP) Platelets >50,000/μL (>75,000 if ongoing bleeding)
Massive Transfusion Protocol (MTP)
Definition: Anticipated need for ≥10 units PRBC in 24h OR ≥4 units in 1h OR entire blood volume replaced
Activation Criteria:
  • Shock Index ≥1.4
  • Clinical assessment suggests massive ongoing haemorrhage
  • Senior clinician decision
Protocol:
🚨 MASSIVE TRANSFUSION PROTOCOL
COMMUNICATION:
□ Call blood bank: "Activating MTP for PPH in [location]"
□ Designated person for blood collection/delivery
INITIAL PACK (while crossmatch pending):
- 4 units O-negative or group-specific PRBC
- 4 units FFP
- Arrange platelets
ONGOING (balanced resuscitation):
Ratio: PRBC : FFP : Platelets = 1 : 1 : 1
LABORATORY MONITORING (every 30-60 min):
- CBC
- PT/INR, aPTT
- Fibrinogen
- ABG with lactate
- Calcium (citrate in blood products chelates calcium)
TARGETS:
- Hb >7-8 g/dL
- Platelets >50,000/μL
- PT/aPTT <1.5× normal
- Fibrinogen >2 g/L
- Ionized Calcium >1.1 mmol/L (give Calcium gluconate if low)
- pH >7.2
- Temperature >35°C
ADJUNCTS:
- Tranexamic acid 1g IV if not already given
- Calcium gluconate 10 mL of 10% solution IV for hypocalcemia
- Warm all blood products and fluids
🚨 Hypothermia, acidosis, and hypocalcemia worsen coagulopathy. Treat aggressively.

SECTION 5: MECHANICAL AND SURGICAL INTERVENTIONS


5.1 TEMPORIZING MEASURES

External Aortic Compression
Indication: Temporizing measure during resuscitation or while preparing for surgery
TECHNIQUE:
1. Patient supine
2. Locate umbilicus
3. Make fist and place on midline, just above umbilicus
4. Press firmly downward toward vertebral column
5. Check femoral pulse with other hand – should be absent/diminished
6. Maintain until definitive measures instituted
7. Tiring – may need to rotate personnel
Bimanual Uterine Compression
Indication: Atony; temporizing while uterotonics take effect
TECHNIQUE:
1. One hand: Make fist, insert into anterior vaginal fornix
Push upward against lower uterine segment
2. Other hand: On abdomen, cup posterior wall of uterus
3. Compress uterus firmly between both hands
4. Maintain continuously until uterus contracts and remains firm
5. May need to continue for 15-30+ minutes
6. Continue uterotonics, prepare next steps

5.2 UTERINE BALLOON TAMPONADE (UBT)

Indication:
  • Atony unresponsive to uterotonics
  • Can be used while preparing for surgical intervention
  • ”Tamponade test“ – if bleeding stops with balloon, likely atony; if continues, consider other causes or proceed to surgery
Commercial Balloons
Product Characteristics
Bakri balloon Purpose-built, drainage channel, can measure ongoing loss
Ebb balloon Dual balloon (uterine + vaginal)
BT-Cath Similar to Bakri
Condom Catheter (Resource-Limited Alternative)
Equally effective as commercial balloons
MATERIALS:
- Foley catheter (22-24 Fr) or rubber catheter
- Condom (non-lubricated preferred)
- Silk suture or string
- NS for inflation
PREPARATION:
1. Cut distal tip of Foley (if using Foley)
2. Tie condom firmly onto catheter end with silk (double tie)
3. Check for leaks by inflating with water
INSERTION:
1. Confirm uterus is empty (no retained products/clots)
2. Aseptic technique
3. Insert catheter with condom into uterine cavity
(may use sponge forceps to guide)
4. Inflate with warm NS – typically 250-500 mL
5. Inflate until resistance felt OR bleeding stops
6. Clamp catheter
7. Pack vagina lightly with gauze to prevent expulsion (optional)
8. Start or continue oxytocin infusion
9. Tape catheter to thigh
MONITORING:
- Check pad for ongoing bleeding
- Monitor vitals continuously
- Check balloon is in place
REMOVAL:
- Leave in situ for 12-24 hours
- Deflate gradually (50-100 mL at a time over several hours)
- Have uterotonics, blood ready
- Remove once fully deflated and no bleeding
Positive ”Tamponade Test“: Bleeding stops with balloon inflation → Confirms atony as cause; continue balloon therapy
Negative ”Tamponade Test“: Bleeding continues → Other cause or need for surgical intervention

5.3 UTERINE COMPRESSION SUTURES

Indication: Atony at laparotomy; failed UBT
B-Lynch Suture (Most Common)
TECHNIQUE:
Prerequisites:
- Laparotomy performed
- Uterus exteriorized
- Bladder reflected down (if not already for CS)
Test compression first:
- Assistant compresses uterus bimanually
- If bleeding stops with compression, suture will likely work
Suture material: No. 1 or No. 2 absorbable suture (Chromic catgut,
Polyglactin) on large needle
Steps:
1. Enter uterus 3 cm below right edge of incision, 3 cm from
lateral border; exit 3 cm above incision
2. Pass suture over fundus to posterior wall (approximately
4 cm from cornua)
3. Enter posterior wall at level of uterosacral ligament
insertion, exit on same level on left side
4. Pass suture back over fundus on left side
5. Enter anterior wall 3 cm above left edge of incision;
exit 3 cm below incision
6. While assistant compresses uterus, pull both ends of suture
tight and tie securely
7. Close uterine incision (if CS)
Post-procedure:
- Confirm haemostasis
- May place drain
- Consider antibiotics
Other Compression Sutures
Suture Description
Hayman
Simpler; does not require uterine incision; vertical sutures from anterior to posterior
Cho (Square sutures)
Multiple square sutures through full thickness; good for focal bleeding
Pereira
Combination of transverse and longitudinal sutures

5.4 VASCULAR LIGATION

Indication: Bleeding despite compression sutures or UBT; not involving uterine atony (e.g., trauma, extensions); desire to preserve fertility
Uterine Artery Ligation (O’Leary Sutures)
TECHNIQUE:
1. Identify uterine artery – runs along lateral aspect of lower
uterine segment (can often be seen pulsating)
2. Create window in broad ligament avascular area
3. Pass suture (No. 1 absorbable) through myometrium at level
of internal os, 2-3 cm medial to artery, from front to back
4. Tie on lateral side, including artery and veins
5. Repeat on other side
6. If bleeding continues, may ligate ascending branches higher
(at cornual level)
Internal Iliac (Hypogastric) Artery Ligation
Indication: Severe uncontrolled hemorrhage; experienced surgeon
TECHNIQUE OVERVIEW:
1. Open posterior peritoneum lateral to iliac vessels
2. Identify and retract ureter medially
3. Identify bifurcation of common iliac into external and
internal iliac arteries
4. Internal iliac is medial and posterior
5. Carefully dissect around internal iliac artery (avoid vein
posteriorly)
6. Pass right-angled clamp behind artery, 2-3 cm distal to
bifurcation (to preserve posterior division if possible)
7. Pass ligature and tie (do not cut artery)
8. Repeat on other side
Reduces pulse pressure by 85%, allowing clot formation
⚠️ Complications: Ureteric injury, venous injury, buttock
claudication (rare)

5.5 HYSTERECTOMY

Indication:
  • Life-threatening haemorrhage unresponsive to conservative measures
  • Placenta accreta spectrum with uncontrollable bleeding
  • Uterine rupture not amenable to repair
  • DO NOT DELAY when indicated – maternal life takes priority
When to Proceed to Hysterectomy
DECISION POINTS:
Consider hysterectomy when:
□ Massive haemorrhage despite optimal uterotonic therapy
□ Failed UBT and/or compression sutures
□ Failed vascular ligation
□ Uterine rupture with extensive damage
□ Placenta accreta/increta/percreta with uncontrollable bleeding
□ Total blood replacement approaching/exceeding
Decision must balance:
- Rate of ongoing bleeding
- Resources available (blood, surgical expertise)
- Patient stability
- Future fertility wishes (discuss if time permits, but life > fertility)
⚠️ A timely subtotal hysterectomy is better than a delayed total
hysterectomy in a dying patient
Subtotal vs Total Hysterectomy
Type Advantages Disadvantages
Subtotal (Supracervical)
Faster, less urological injury, less blood loss Cervical stump may bleed if placenta praevia/accreta
Total
Definitive; no cervical stump issues Longer, more technically demanding, higher complication risk
Choice depends on:
  • Source of bleeding (low = total may be needed)
  • Patient stability (unstable = subtotal and pack)
  • Surgical expertise
Damage Control Surgery Concept
In extreme haemorrhage with coagulopathy, hypothermia, acidosis:
DAMAGE CONTROL APPROACH:
1. Abbreviated surgery:
- Control bleeding (hysterectomy if needed, or packing)
- Pack pelvis and close abdomen
2. ICU resuscitation:
- Warm patient
- Correct coagulopathy
- Correct acidosis
- Massive transfusion
3. Re-look surgery (24-48h):
- Remove packs
- Complete definitive repair
- Close abdomen definitively

5.6 INTERVENTIONAL RADIOLOGY (Where Available)

Procedure Indication
Uterine artery embolization
Atony, accreta (pre-planned), AV malformation, pseudo-aneurysm
Internal iliac artery embolization
Broader haemorrhage control
Balloon occlusion (planned)
Anticipated accreta; placed before CS
Prerequisites:
  • Haemodynamically stable enough to tolerate procedure (~1h)
  • Interventional radiology available 24/7
  • Hybrid OR ideal

SECTION 6: BLOOD TRANSFUSION PROTOCOLS


6.1 INDICATIONS FOR TRANSFUSION

Product Indication Dose
PRBC
Hb <7 g/dL (or <8 g/dL in cardiac disease or ongoing bleeding) 1 unit raises Hb by ~1 g/dL
FFP
PT/INR or aPTT >1.5× normal; empiric in massive transfusion 15-20 mL/kg
Platelets
<50,000/μL with bleeding; <75,000/μL in ongoing haemorrhage 1 adult dose
Cryoprecipitate
Fibrinogen <2 g/L 10 units

6.2 EMERGENCY BLOOD

Situation Action
Crossmatch available
Crossmatched blood (safest)
No time for crossmatch
Type-specific uncrossmatched blood (Group compatible)
Unknown blood group, life-threatening
O-negative PRBC (or O-positive if Rh-neg unavailable)
🚨 Never delay transfusion for crossmatch in life-threatening haemorrhage. O-negative or group-specific blood is acceptable.

6.3 TRANSFUSION COMPLICATIONS TO WATCH FOR

Complication Signs Management
Transfusion reaction
Fever, chills, rash, dyspnoea, hypotension Stop transfusion; supportive care; notify blood bank
TACO (overload)
Dyspnoea, hypertension, JVP elevated Slow/stop transfusion; diuretics
TRALI
Acute lung injury within 6h; bilateral infiltrates, hypoxia Supportive; oxygen; may need ventilation
Hypocalcemia
Citrate toxicity; prolonged QT, tetany Calcium gluconate 10 mL 10% IV
Hypothermia
Cold products Use blood warmer
Hyperkalaemia
Especially old blood Monitor potassium; treat if symptomatic

SECTION 7: POST-RESUSCITATION CARE


7.1 IMMEDIATE POST-EVENT (First 2-6 Hours)

Action Details
Monitoring
ICU/HDU level care if severe PPH; q15-30 min vitals initially
Uterine tone
Continue to assess; continue oxytocin infusion for minimum 4 hours
Urine output
Target ≥0.5 mL/kg/hr; Foley remains in situ
Bleeding
Monitor pad/drapes; ongoing bleeding → reassess
Labs
Repeat CBC, coagulation at 2-4 hours; ABG if was acidotic
VTE prophylaxis
Graduated compression stockings; mechanical prophylaxis while bleeding risk persists

7.2 INVESTIGATIONS TO EXCLUDE ONGOING ISSUES

Investigation Purpose
Serial CBC Confirm Hb stable; may continue to drop with fluid shifts
Coagulation (PT, aPTT, fibrinogen) Ensure normalized; guide further blood products
RFT Exclude acute kidney injury
LFT Baseline; especially if HELLP/preeclampsia
ABG/Lactate Ensure clearance of acidosis
Echo If suspected cardiac injury (AFE, massive transfusion)

7.3 LONGER TERM CARE

Issue Management
Anaemia
Oral iron supplementation; may need continued transfusion if symptomatic/Hb <7
Sheehan syndrome
Suspect if failure to lactate; test pituitary function (TSH, cortisol, etc.)
Thromboprophylaxis
Low molecular weight heparin once haemostasis secured (usually 24-48h post); balance bleeding vs clot risk
Psychological
Debrief patient; watch for PTSD; offer counseling
Contraception
Discuss timing of future pregnancy; may need interval for recovery

7.4 IRON REPLACEMENT THERAPY

Route Indication Options
Oral
Mild-moderate anaemia, tolerating oral Ferrous sulfate 200 mg TDS (60 mg elemental iron TDS); take with vitamin C; avoid with tea/antacids
IV
Severe anaemia (Hb <8), intolerance to oral, rapid correction needed Ferric carboxymaltose 1000 mg single dose (or 500 mg × 2); Iron sucrose 200 mg × 5 doses

SECTION 8: SPECIAL SITUATIONS


8.1 SECONDARY PPH (>24 Hours – 12 Weeks)

Causes
Cause Frequency
Subinvolution of placental site ± infection Most common
Retained products of conception Common
Endometritis Common
Pseudoaneurysm of uterine artery Rare
Gestational trophoblastic disease Rare
Management
ASSESSMENT:
□ Vitals, shock assessment
□ Bleeding – amount, clots
□ Signs of infection – fever, offensive lochia, uterine tenderness
□ Speculum – source of bleeding, cervical os open?
□ Bimanual – uterine size, tenderness
INVESTIGATIONS:
□ CBC, Group & Save
□ Ultrasound – retained products? Endometrial thickness >10mm?
□ βhCG if GTD suspected
TREATMENT:
1. Resuscitation if needed (as per primary PPH)
2. Uterotonics:
- Oxytocin 10 IU IM + infusion
- Misoprostol 400-600 mcg SL/PO
3. Antibiotics (presumptive infection):
- Ampicillin + Gentamicin + Metronidazole
- OR Amoxicillin-clavulanate + Metronidazole
4. Surgical evacuation if retained products:
- Ultrasound-guided if possible
- Gentle suction curettage
- Risk of perforation (soft postpartum uterus)
5. Consider embolization if AV malformation/pseudoaneurysm
6. Rarely → hysterectomy if uncontrolled

8.2 JEHOVAH’S WITNESS (REFUSAL OF BLOOD)

Principles
  • Respect autonomy if competent adult with informed refusal
  • Document advance directive clearly
  • Optimize alternatives
  • Discuss with hospital ethics/legal if needed
Alternatives to Blood Transfusion
Intervention Details
Cell salvage
May be acceptable to some JW (own blood recycled)
Tranexamic acid
Give early
IV Iron
Pre-operatively if time
Erythropoietin
Pre-operatively if time (EPO 40,000 units SC weekly)
Minimize blood loss
Meticulous haemostasis, UBT, compression sutures
Tolerate lower Hb
May tolerate Hb as low as 5-6 g/dL if normovolemic and not bleeding
Minimize phlebotomy
Paediatric tubes; minimize testing

8.3 PPH AFTER CAESAREAN SECTION

Additional Considerations Details
Higher expected blood loss 1000 mL threshold for ”severe“
Visible causes Extensions of incision, broad ligament haematoma, coagulopathy
Lower segment atony May need figure-of-8 sutures at angles
Placenta accreta spectrum Higher risk if previous CS + anterior placenta
Rapid access to abdominal cavity Already open or can re-open quickly

8.4 JEERING WITH PLACENTA ACCRETA SPECTRUM

Risk Factors
Factor Relative Risk
Previous CS + Placenta praevia Highest risk
1 prior CS + praevia ~3% accreta
2 prior CS + praevia ~11% accreta
≥3 prior CS + praevia ~40% accreta
Previous myomectomy Increased risk
Previous curettage Increased risk
Pre-operative Planning (Suspected Accreta)
MULTIDISCIPLINARY PLANNING:
Team:
□ Senior obstetrician (experienced in accreta)
□ Senior anaesthetist
□ Blood bank (crossmatch ≥6 units PRBC, FFP, platelets on standby)
□ Interventional radiology (if available)
□ Urology (if bladder involvement suspected)
□ ICU
Pre-operative:
□ Confirm diagnosis (MRI if unclear on USS)
□ Counseling – high likelihood of hysterectomy
□ Consent for hysterectomy
□ Cell salvage available
□ Adequate IV access (large bore × 2, ± central line)
□ Arterial line
□ Warm products and fluids
Operative strategy:
□ Midline vertical incision (adequate access)
□ Classical uterine incision (avoid placenta)
□ Deliver baby
□ DO NOT attempt to remove placenta if accreta confirmed
□ Hysterectomy with placenta in situ
□ Consider ureteric stents pre-op if percreta
□ Consider iliac balloon catheters (IR)

SECTION 9: DOCUMENTATION


9.1 ESSENTIAL DOCUMENTATION

PPH DOCUMENTATION CHECKLIST:
□ Time PPH recognised
□ Estimated blood loss (method used)
□ Vitals at recognition and serially
□ Shock Index
□ Team members present
□ Call for help time
□ Uterotonic drugs given (drug, dose, route, time)
□ Tranexamic acid (dose, time)
□ IV fluids (type, volume, time)
□ Blood products (type, units, time)
□ Procedures performed:
- Uterine massage
- Bimanual compression
- UBT (type, volume, time in/out)
- Examination under anaesthesia
- Surgical procedures (detail technique, suture material)
□ Cause identified (Tone/Trauma/Tissue/Thrombin)
□ Placenta and membrane – complete/incomplete
□ Repairs performed (tears – degree, location)
□ Total blood loss
□ Vital signs at end
□ Transfer to ICU/HDU (time, receiving team)
□ Communication with family

9.2 DEBRIEF

TEAM DEBRIEF (Within 24 hours):
1. What went well?
2. What could be improved?
3. Were protocols followed?
4. Any equipment/supply issues?
5. Any communication issues?
6. Learning points for the team
7. Support for team members (especially if adverse outcome)
Document key learning points and action items

9.3 PATIENT DEBRIEF

Component Details
Timing
Before discharge and at postnatal follow-up
What happened
Explain events in understandable terms
Why it happened
Cause if known
What was done
Interventions, transfusions, surgery
Implications
Effect on future fertility/pregnancies
Emotional support
Acknowledge trauma; offer counseling if needed
Written summary
Provide discharge summary with key details
Follow-up plan
When to return, red flags

SECTION 10: SIMULATION AND DRILLS


10.1 IMPORTANCE OF DRILLS

  • PPH is unpredictable and progresses rapidly
  • Team coordination is critical
  • Regular drills improve response time and outcomes
  • Identifies system gaps (equipment, protocols, communication)
Type Frequency
PPH simulation
Monthly at minimum
MTP activation drill
Quarterly
Full team drill with debrief
Quarterly

QUICK REFERENCE CARDS


📋 PPH QUICK CARD (PRIMARY CARE)

🚨 PPH RECOGNISED – START CLOCK
□ CALL FOR HELP + ACTIVATE REFERRAL
□ A – Airway, Breathing, Oxygen (8-10 L/min)
□ C – 2 large-bore IV (16-18G)
Crystalloid 1-2 L rapid bolus
Bloods: Group, X-match, CBC, Coag
□ M – MASSAGE uterus (bimanual)
□ O – OXYTOCIN 10 IU IM + infusion 20-40 IU in 500 mL NS
MISOPROSTOL 800 mcg SL (if oxytocin inadequate)
□ T – TRANEXAMIC ACID 1 g IV over 10 min (within 3h)
□ I – Identify cause (Tone / Trauma / Tissue / Thrombin)
Empty bladder (catheterize)
Examine placenta, genital tract
□ V – Vital signs q5-15 min; Shock Index
□ E – Escalate / Transfer if:
- Bleeding continues despite above
- Shock Index ≥1.0
- Needs transfusion or surgery
□ NASG if available during transfer
□ Continue massage, uterotonics, IV during transport
RECEIVING FACILITY: _______________
CONTACT: _______________
ETA: _______________

📋 PPH QUICK CARD (SECONDARY/TERTIARY)

🚨 SEVERE PPH / REFRACTORY TO FIRST-LINE
TIME: _____ TEAM LEADER: _____
□ CONFIRM adequate resuscitation:
- 2 large IV, rapid crystalloid 1-2L
- Tranexamic acid 1g given
- Oxytocin loading + infusion running
- Misoprostol given
- Uterine massage ongoing
□ ADD second-line uterotonics:
- Methylergometrine 0.2 mg IM (if no HTN)
- Carboprost 250 mcg IM q15min (if no asthma)
□ IDENTIFY CAUSE:
- Atony → continue massage, bimanual compression
- Trauma → EUA, repair
- Tissue → MVA/curettage under anaesthesia
- Thrombin → blood products (FFP, cryo, platelets)
□ ACTIVATE MTP if Shock Index ≥1.4 or massive ongoing loss
- PRBC : FFP : Platelets = 1:1:1
- Target Hb >8, Plt >50k, Fib >2, Ca++, correct acidosis
□ UTERINE BALLOON TAMPONADE:
- Bakri or condom catheter
- Inflate 250-500 mL NS
- If bleeding stops → leave 12-24h
- If bleeding continues → OT
□ LAPAROTOMY if UBT fails or cause surgical:
- Compression sutures (B-Lynch, Hayman)
- Uterine artery ligation
- Internal iliac ligation
- HYSTERECTOMY (don't delay if life-saving)
□ POST-RESUSCITATION:
- ICU/HDU transfer
- Continue uterotonics 4h
- Serial labs
- Debrief patient and team
TOTAL BLOOD LOSS: _____ mL
PRODUCTS GIVEN: _____
PROCEDURES: _____

📚 REFERENCES FOR PPH PROTOCOL
INTERNATIONAL GUIDELINES (Primary Evidence Base)

Reference Year Key Content Used

1 WHO recommendations for the prevention and treatment of postpartum haemorrhage 2012, Updated 2023 Uterotonics, TXA, UBT, AMTSL, overall management algorithm
2 WHO recommendations on tranexamic acid for the treatment of postpartum haemorrhage 2017 TXA dosing, timing (within 3 hours)
3 FIGO recommendations on the prevention and treatment of postpartum hemorrhage 2022 Stepwise approach, second-line uterotonics, surgical interventions
4 RCOG Green-top Guideline No. 52: Prevention and Management of Postpartum Haemorrhage 2016 (under review) Risk stratification, mechanical interventions, surgical techniques
5 ACOG Practice Bulletin No. 183: Postpartum Hemorrhage 2017, Reaffirmed 2019 Quantitative blood loss, massive transfusion
6 International Society of Blood Transfusion (ISBT) – Massive Transfusion Guidelines 2020 MTP ratios, targets
KEY TRIALS

Trial/Study Journal/Year Key Finding Used

7 WOMAN Trial (World Maternal Antifibrinolytic Trial) Lancet 2017 TXA reduces death from bleeding by ~20-30% if given within 3 hours
8 WOMAN-2 Trial Lancet Global Health 2023 TXA in anaemic women (ongoing/results)
9 WHO Multicountry Survey on Maternal and Newborn Health BJOG 2014 PPH epidemiology, risk factors
10 Cochrane Review: Uterotonic agents for preventing PPH Cochrane 2018, Updated 2020 Comparative effectiveness of uterotonics
11 Cochrane Review: Uterine balloon tamponade for PPH Cochrane 2020 Evidence for UBT effectiveness
12 ESA-ESICM Guidelines on Massive Hemorrhage Eur J Anaesthesiol 2023 Coagulopathy management, transfusion targets
INDIAN GUIDELINES & GOVERNMENT DOCUMENTS

Reference Issuing Body Year Key Content

13 FOGSI GCPR on Prevention and Management of PPH Federation of Obstetric & Gynaecological Societies of India 2016, Updated 2021 India-specific recommendations, drug availability
14 LaQshya – Labour Room Quality Improvement Initiative Guidelines Ministry of Health & Family Welfare, Government of India 2017 Labour room protocols, emergency management
15 Skilled Birth Attendant (SBA) Training Module Government of India 2010, Revised AMTSL, initial PPH management at primary level
16 Guidelines for BEmONC (Basic Emergency Obstetric and Newborn Care) Government of India 2010 Primary care level management
17 Guidelines for CEmONC (Comprehensive Emergency Obstetric and Newborn Care) Government of India 2010 Referral level management, surgical interventions
18 Maternal and Newborn Health Toolkit Ministry of Health & Family Welfare 2013 Operational guidelines for facilities
19 FOGSI Position Paper on Use of Tranexamic Acid in PPH FOGSI 2018 TXA adoption in India
20 National Guidelines for Blood Transfusion Services NACO/NBTC 2020 Blood transfusion protocols for India
21 Maternal Death Surveillance and Response (MDSR) Guidelines Government of India 2017 Reporting, review of maternal deaths
22 ICMR-FOGSI Guidelines on Iron Deficiency Anaemia in Pregnancy ICMR/FOGSI 2021 Anaemia management context
TEXTBOOKS & ADDITIONAL RESOURCES

Reference Details

23 Williams Obstetrics 26th Edition (2022) Chapter on Obstetric Hemorrhage
24 Arias’ Practical Guide to High-Risk Pregnancy and Delivery 4th Edition PPH management
25 DC Dutta’s Textbook of Obstetrics 9th Edition (2018) Commonly used Indian textbook
26 Management of Labour – FOGSI Focus Series Practical guidance
27 B-Lynch Suture Technique – Original description B-Lynch et al., BJOG 1997
ONLINE RESOURCES
🛡️

Medical Advisory

Clinical guidelines are subject to change. Physicians should exercise their regular clinical judgment. This protocol does not replace individual institutional policies. Verified for Q1 2026.

Content Feedback

Is this information helpful?

Help us improve our clinical database for the medical community.

All feedback is reviewed by our clinical editorial team.